Decoy Therapeutics is trading at $5.81 (-7.26%) as the stock continues to experience sharp volatility following its recent capital raise.
- The price action follows a $21 million PIPE financing announced on June 26, with shares swinging significantly around deal terms and warrant milestones.
- The downward move appears idiosyncratic to the company, as broader U.S. markets are trading slightly higher and no new catalysts were reported for July 10.